US Patent 7307150 Dextran-hemoglobin conjugates as blood substitutes
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jeffrey Tze-Fei Wong0
Sheung Pun Tsai0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+331 characters)
Article
Patent abstract
An hemoglobin (Hb)-Dextran (Dx) conjugate having a molecular weight between 50 kd and 500 kD provides a blood substitute that results in acceptable erythrocyte sedimentation rate (ESR) and excretion rate (EXC) values. DxHb conjugates of the invention can be used for a variety of purposes as an alternative to blood.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07307150 Dextran-hemoglobin conjugates as blood substitutes US Patent 7307150 Dextran-hemoglobin conjugates as blood substitutes
Infobox
Patent Number
073071500
Patent Number
73071500
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073071500
Date of Patent
December 11, 2007
0Patent Application Number
109753240
Date Filed
October 28, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07307150 Dextran-hemoglobin conjugates as blood substitutes
Infobox
Is a
Patent jurisdiction
Patent number
07307150
Date of patent
December 11, 2007
Patent application number
10975324
Date Filed
October 28, 2004
Patent primary examiner
Find more entities like US Patent 7307150 Dextran-hemoglobin conjugates as blood substitutes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
